Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Assets Average: 2020-2025

Historic Assets Average for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Sep 2025 value amounting to $361.7 million.

  • Arcutis Biotherapeutics' Assets Average fell 17.99% to $361.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $361.7 million, marking a year-over-year decrease of 17.99%. This contributed to the annual value of $345.1 million for FY2024, which is 12.70% down from last year.
  • Arcutis Biotherapeutics' Assets Average amounted to $361.7 million in Q3 2025, which was up 3.86% from $348.3 million recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Assets Average registered a high of $479.1 million during Q4 2022, and its lowest value of $306.8 million during Q3 2023.
  • Moreover, its 3-year median value for Assets Average was $361.7 million (2025), whereas its average is $377.3 million.
  • In the last 5 years, Arcutis Biotherapeutics' Assets Average soared by 90.68% in 2021 and then plummeted by 33.80% in 2023.
  • Over the past 5 years, Arcutis Biotherapeutics' Assets Average (Quarterly) stood at $397.6 million in 2021, then rose by 20.50% to $479.1 million in 2022, then plummeted by 33.80% to $317.2 million in 2023, then grew by 23.95% to $393.1 million in 2024, then fell by 17.99% to $361.7 million in 2025.
  • Its Assets Average was $361.7 million in Q3 2025, compared to $348.3 million in Q2 2025 and $346.5 million in Q1 2025.